Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Phytel

Explore full profile

Prescription, lab and clinical data for health and disease management

Farmers Branch, United StatesFounded 1996Health Tech & Medtech
Valuation $50–100M Last recorded · 2010
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Phytel and the history behind them.

About Phytel

Phytel, a subsidiary of IBM, specializes in AI-driven healthcare solutions aimed at improving patient engagement, care coordination, and population health management. Operating in the healthcare technology market, Phytel serves healthcare providers, including hospitals and clinics, by offering tools that automate and streamline patient care processes. The business model focuses on subscription-based services, where clients pay for access to Phytel's suite of software solutions. Revenue is generated through these subscriptions and additional services such as training and support. Phytel leverages IBM's cloud infrastructure to ensure high availability and scalability of its services, making it a reliable partner for healthcare organizations looking to enhance their operational efficiency and patient outcomes.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
1996
Headquarters
Farmers Branch, United States
Employees
9
Open positions
None listed
Dealroom signal
60.5/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Hard Tech
Client focus
b2b

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit May 2015 $0 — IBM —
DEBT✓Debt Aug 2013 $5M — Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Phytel website traffic

Latest recorded traffic for Phytel is 280 monthly website visits, up 100% over the last three months. Phytel's team declined 65.4% over the past year.

Latest monthly visits280 3-month web change+100% 1-year team growth-65.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

Other known investors1 additional known investor

  • IBM
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Phytel on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Phytel’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.